CIK: 0001595851 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 16, 2015
Total Value: $222M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Allergan PLC | 37,500 | $10.19M | 4.6% | $303.47 | — | SHS | G0177J108 |
| — | NUVASIVE INC | 175,000 | $8.439M | 3.8% | $44.27 | — | COM | 670704105 |
| — | FIVE PRIME THERAPEUTICS INC | 500,000 | $7.695M | 3.5% | $23.02 | — | COM | 33830X104 |
| — | MALLINCKRODT PUB LTD CO | 120,000 | $7.673M | 3.5% | $63.94 | — | SHS | G5785G107 |
| — | ZELTIQ AESTHETICS INC | 235,000 | $7.527M | 3.4% | $27.54 | — | COM | 98933Q108 |
| — | NANOSTRING TECHNOLOGIES INC | 450,000 | $7.2M | 3.2% | $13.25 | — | COM | 63009R109 |
| AMGN | AMGEN INC | 50,000 | $6.916M | 3.1% | $116.24 | 0.0% | COM | 031162100 |
| GILD | GILEAD SCIENCES INC | 70,000 | $6.873M | 3.1% | $77.50 | 0.0% | COM | 375558103 |
| — | CELGENE CORP | 60,000 | $6.49M | 2.9% | $108.17 | — | COM | 151020104 |
| — | ALNYLAM PHARMACEUTICALS INC | 75,000 | $6.027M | 2.7% | — | — | Call | 02043Q907 |
| — | BRISTOL MYERS SQUIBB CO | 100,000 | $5.92M | 2.7% | — | — | Call | 110122908 |
| — | FLAMEL TECHNOLOGIES SA | 350,000 | $5.709M | 2.6% | $19.78 | — | SPONSORED ADR | 338488109 |
| EW | EDWARDS LIFESCIENCES CORP | 40,000 | $5.687M | 2.6% | $24.14 | 0.0% | COM | 28176E108 |
| — | HORIZON PHARMA PLC | 275,000 | $5.451M | 2.5% | $30.67 | — | SHS | G4617B105 |
| CYH | COMMUNITY HEALTH SYS INC NEW | 120,000 | $5.132M | 2.3% | $45.85 | 0.0% | COM | 203668108 |
| — | ZOGENIX INC | 370,000 | $4.995M | 2.2% | $13.50 | — | COM | 98978L204 |
| — | HEARTWARE INTL INC | 90,000 | $4.708M | 2.1% | $52.31 | — | COM | 422368100 |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | 75,000 | $4.466M | 2.0% | $31.27 | 0.0% | COM | 457985208 |
| — | ALCOBRA LTD | 688,961 | $4.161M | 1.9% | $5.68 | — | SHS | M2239P109 |
| — | GENMARK DIAGNOSTICS INC | 525,000 | $4.132M | 1.9% | $9.06 | — | COM | 372309104 |
| — | DYNAVAX TECHNOLOGIES CORP | 165,000 | $4.049M | 1.8% | $24.54 | — | COM | 268158102 |
| HCA | HCA HOLDINGS INC | 50,000 | $3.868M | 1.7% | $82.31 | 0.0% | COM | 40412C101 |
| — | AEGERION PHARMACEUTICALS INC | 250,000 | $3.4M | 1.5% | $13.60 | — | COM | 00767E102 |
| PCRX | PACIRA PHARMACEUTICALS INC | 80,000 | $3.288M | 1.5% | $61.25 | 0.0% | COM | 695127100 |
| ISRG | INTUITIVE SURGICAL INC | 7,000 | $3.217M | 1.4% | $55.94 | +1.3% | COM NEW | 46120E602 |
| — | SYNERGY PHARMACEUTICALS INC | 600,000 | $3.18M | 1.4% | $5.30 | — | COM | 871639308 |
| — | ATARA BIOTHERAPEUTICS INC | 100,000 | $3.144M | 1.4% | $52.76 | — | COM | 046513107 |
| QURE | UNIQURE B.V. | 150,000 | $3.068M | 1.4% | $28.48 | -7.5% | SHS | N90064101 |
| — | SPECTRANETICS CORP | 250,000 | $2.948M | 1.3% | $11.79 | — | COM | 84760C107 |
| — | THERAPEUTICSMD INC | 500,000 | $2.93M | 1.3% | — | — | Call | 88338N907 |
| — | BELLICUM PHARMACEUTICALS INC | 200,000 | $2.906M | 1.3% | $14.53 | — | COM | 079481107 |
| — | CYNAPSUS THERAPEUTICS INC | 175,000 | $2.83M | 1.3% | $16.29 | — | COM | 23257Y859 |
| INCY | INCYTE CORP | 25,000 | $2.758M | 1.2% | $112.12 | 0.0% | COM | 45337C102 |
| — | VITAE PHARMACEUTICALS INC | 250,000 | $2.753M | 1.2% | $11.71 | — | COM | 92847N103 |
| — | GW PHARMACEUTICALS PLC | 30,000 | $2.741M | 1.2% | $103.82 | — | ADS | 36197T103 |
| — | ACORDA THERAPEUTICS INC | 100,000 | $2.651M | 1.2% | $26.51 | — | COM | 00484M106 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 225,000 | $2.565M | 1.2% | $12.95 | +3.1% | COM | 09058V103 |
| — | HERON THERAPEUTICS INC | 100,000 | $2.44M | 1.1% | — | — | Call | 427746902 |
| — | RELYPSA INC | 120,000 | $2.221M | 1.0% | $18.51 | — | COM | 759531106 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 55,000 | $2.188M | 1.0% | $42.40 | +14.0% | COM | 64125C109 |
| — | TONIX PHARMACEUTICALS HOLDIN | 398,300 | $2.107M | 0.9% | $7.16 | — | COM | 890260201 |
| — | ZAFGEN INC | 65,000 | $2.077M | 0.9% | $31.95 | — | COM | 98885E103 |
| — | ACHILLION PHARMACEUTICALS | 300,000 | $2.073M | 0.9% | $6.91 | — | COM | 00448Q201 |
| — | NEURODERM LTD | 100,000 | $2.067M | 0.9% | $20.67 | — | COM | M74231107 |
| — | PTC THERAPEUTICS INC | 75,000 | $2.003M | 0.9% | — | — | Call | 69366J900 |
| CLLS | CELLECTIS - ADR | 75,000 | $1.977M | 0.9% | $36.08 | — | SPONSORED ADS | 15117K103 |
| — | EPIZYME INC | 150,000 | $1.929M | 0.9% | $21.60 | — | COM | 29428V104 |
| — | LION BIOTECHNOLOGIES INC | 300,000 | $1.728M | 0.8% | $10.85 | — | COM | 53619R102 |
| — | SAGE THERAPEUTICS INC | 40,800 | $1.727M | 0.8% | $50.23 | — | COM | 78667J108 |
| ASND | ASCENDIS PHARMA A/S - ADR | 97,135 | $1.719M | 0.8% | $17.69 | — | ADR | 04351P101 |
| — | GENOCEA BIOSCIENCES INC | 220,000 | $1.507M | 0.7% | $11.86 | — | COM | 372427104 |
| — | DERMA SCIENCES INC | 300,000 | $1.413M | 0.6% | $4.71 | — | COM | 249827502 |
| ACHC | ACADIA PHARMACEUTICALS | 40,000 | $1.323M | 0.6% | $76.93 | 0.0% | COM | 00404A109 |
| RGNX | REGENXBIO INC | 60,000 | $1.322M | 0.6% | $25.52 | 0.0% | COM | 75901B107 |
| — | CHIASMA INC | 65,000 | $1.292M | 0.6% | $19.88 | — | COM | 16706W102 |
| — | CORIUM INTERNATIONAL INC | 125,000 | $1.169M | 0.5% | $9.35 | — | COM | 21887L107 |
| — | FOAMIX PHARMACEUTICALS LTD | 150,000 | $1.1M | 0.5% | $10.25 | — | SHS | M46135105 |
| — | PORTOLA PHARMACEUTICALS INC | 25,000 | $1.066M | 0.5% | $27.98 | — | COM | 737010108 |
| CPRX | CATALYST PHARM PARTNERS INC | 350,000 | $1.05M | 0.5% | $4.32 | 0.0% | COM | 14888U101 |
| VCYT | VERACYTE INC | 202,800 | $951K | 0.4% | $9.65 | -1.3% | COM | 92337F107 |
| — | CYMABAY THERAPEUTICS INC | 400,000 | $776K | 0.3% | $1.94 | — | COM | 23257D103 |
| — | BIODELIVERY SCIENCES INTL IN | 106,200 | $590K | 0.3% | — | — | Call | 09060J906 |
| — | BIODELIVERY SCIENCES INTERNATIONAL INC | 100,000 | $556K | 0.3% | $7.96 | — | COM | 09060J106 |
| PBYI | PUMA BIOTECHNOLOGY INC | 6,500 | $490K | 0.2% | $214.23 | -55.9% | COM | 74587V107 |
| — | AKARI THERAPEUTICS PLC | 20,325 | $488K | 0.2% | $24.01 | — | SHS | 00972G108 |
| FATE | FATE THERAPEUTICS INC | 89,231 | $476K | 0.2% | $6.83 | 0.0% | COM | 31189P102 |
| — | SPARK THERAPEUTICS INC | 10,000 | $417K | 0.2% | $41.70 | — | COM | 84652J103 |
| — | ZOSANO PHARMA CORP | 100,000 | $396K | 0.2% | $3.96 | — | COM | 98979H103 |
| — | OCERA THERAPEUTICS INC | 125,000 | $395K | 0.2% | $10.04 | — | COM | 67552A108 |
| — | UNILIFE CORP NEW | 350,000 | $343K | 0.2% | $4.01 | — | COM | 90478E103 |
| SRPT | SAREPTA THERAPEUTICS INC | 10,000 | $321K | 0.1% | $33.93 | 0.0% | COM | 803607100 |
| — | RAPTOR PHARMACEUTICAL CORP | 50,000 | $303K | 0.1% | $6.06 | — | COM | 75382F106 |
| — | BIOLASE INC | 300,000 | $270K | 0.1% | $2.41 | — | COM | 090911108 |
| — | SUNESIS PHARMACEUTICALS INC | 292,939 | $237K | 0.1% | $2.45 | — | COM | 867328601 |